Ji X, Zhang P, Armstrong R N, Gilliland G L
Center for Advanced Research in Biotechnology, Maryland Biotechnology Institute, University of Maryland, Shady Grove.
Biochemistry. 1992 Oct 27;31(42):10169-84. doi: 10.1021/bi00157a004.
The crystal structure of a mu class glutathione S-transferase (EC 2.5.1.18) from rat liver (isoenzyme 3-3) in complex with the physiological substrate glutathione (GSH) has been solved at 2.2-A resolution by multiple isomorphous replacement methods. The enzyme crystallized in the monoclinic space group C2 with unit cell dimensions of a = 87.98 A, b = 69.41 A, c = 81.34 A, and beta = 106.07 degrees. Oligonucleotide-directed site-specific mutagenesis played an important role in the solution of the structure in that the cysteine mutants C86S, C114S, and C173S were used to help locate the positions of mercuric ion sites in nonisomorphous derivatives with ethylmercuric phosphate and to align the sequence with the model derived from MIR phases. A complete model for the protein was not obtained until part of the solvent structure was interpreted. The dimer in the asymmetric unit refined to a crystallographic R = 0.171 for 19,298 data and I > or = 1.5 sigma (I). The final model consists of 4150 atoms, including all non-hydrogen atoms of 434 amino acid residues, two GSH molecules, and oxygen atoms of 474 water molecules. The dimeric enzyme is globular in shape with dimensions of 53 x 62 x 56 A. Crystal contacts are primarily responsible for conformational differences between the two subunits which are related by a noncrystallographic 2-fold axis. The structure of the type 3 subunit can be divided into two domains separated by a short linker, a smaller alpha/beta domain (domain I, residues 1-82), and a larger alpha domain (domain II, residues 90-217). Domain I contains four beta-strands which form a central mixed beta-sheet and three alpha-helices which are arranged in a beta alpha beta alpha beta beta alpha motif. Domain II is composed of five alpha-helices. Domain I can be considered the glutathione binding domain, while domain II seems to be primarily responsible for xenobiotic substrate binding. The active site is located in a deep (19-A) cavity which is composed of three relatively mobile structural elements: the long loop (residues 33-42) of domain I, the alpha 4/alpha 5 helix-turn-helix segment, and the C-terminal tail. GSH is bound at the active site in an extended conformation at one end of the beta-sheet of domain I with its backbone facing the cavity and the sulfur pointing toward the subunit to which it is bound.(ABSTRACT TRUNCATED AT 400 WORDS)
通过多同晶置换法,已在2.2埃分辨率下解析了大鼠肝脏中μ类谷胱甘肽S-转移酶(EC 2.5.1.18,同工酶3-3)与生理底物谷胱甘肽(GSH)形成复合物的晶体结构。该酶结晶于单斜空间群C2中,晶胞参数为a = 87.98埃,b = 69.41埃,c = 81.34埃,β = 106.07°。寡核苷酸定向位点特异性诱变在结构解析中发挥了重要作用,因为半胱氨酸突变体C86S、C114S和C173S被用于帮助确定在与磷酸乙基汞形成的非同晶衍生物中汞离子位点的位置,并将序列与从MIR相位推导的模型进行比对。直到部分溶剂结构被解析后,才获得了蛋白质的完整模型。不对称单元中的二聚体对19298个数据点(I≥1.5σ(I))精修后的晶体学R值为0.171。最终模型由4150个原子组成,包括434个氨基酸残基的所有非氢原子、两个GSH分子以及474个水分子的氧原子。二聚体酶呈球状,尺寸为53×62×56埃。晶体接触主要导致两个通过非晶体学2重轴相关的亚基之间的构象差异。3型亚基的结构可分为由一个短连接子分隔的两个结构域,一个较小的α/β结构域(结构域I,残基1-82)和一个较大的α结构域(结构域II,残基90-217)。结构域I包含四条β链,形成一个中央混合β折叠片,以及三条α螺旋,它们按βαβαββα基序排列。结构域II由五条α螺旋组成。结构域I可被视为谷胱甘肽结合结构域,而结构域II似乎主要负责外源性底物的结合。活性位点位于一个深(19埃)的腔中,该腔由三个相对可移动的结构元件组成:结构域I的长环(残基33-42)、α4/α5螺旋-转角-螺旋片段和C末端尾巴。GSH以伸展构象结合在结构域I的β折叠片一端的活性位点,其主链面向腔,硫原子指向与之结合的亚基。(摘要截短于400字)